Return to the ‘good old days’ of outcome maximisation? Newsletter Article 09 February 2013 Pages: 2 - 2
Early intervention key to improving outcomes in status epilepticus Carlene Todd Newsletter Article 09 February 2013 Pages: 3 - 5
Time to reassess the management of acute otitis media Newsletter Article 09 February 2013 Pages: 6 - 6
Extra cost of captopril justified in diabetic nephropathy Newsletter Article 09 February 2013 Pages: 6 - 6
Interferon-α-2b cost effective in high-risk resected melanoma? Newsletter Article 09 February 2013 Pages: 7 - 7
Healthcare players view funding decisions differently Newsletter Article 09 February 2013 Pages: 10 - 10
Involve patients in breast cancer treatment decisions Newsletter Article 09 February 2013 Pages: 10 - 10
QOL after antineoplastic therapy for head and neck cancer Newsletter Article 09 February 2013 Pages: 11 - 11
Growth of European OTC drugs market could reduce costs? Newsletter Article 09 February 2013 Pages: 11 - 11
Campaign to uncover rationing of antipsychotics in UK Newsletter Article 09 February 2013 Pages: 11 - 11